Evidence map›Paper›PMID 25041562›Full record

ArticleAddiction (Abingdon, England)2014

Genetic variation in personality traits explains genetic overlap between borderline personality features and substance use disorders.

Lauren R Few, Julia D Grant, Timothy J Trull, Dixie J Statham, Nicholas G Martin, Michael T Lynskey, Arpana Agrawal

Abstract readTwin Study
In one paragraph

Article in Addiction (Abingdon, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Big Five personality traits and alcohol, nicotine, cannabis, and gambling disorder comorbidity.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2019
    Article
  13. Manifesto for a European research network into Problematic Usage of the Internet.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Borderline personality disorder and substance use disorders: an updated review.Borderline personality disorder and emotion dysregulation · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren R FewDepartment of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
Julia D Grant
Timothy J Trull
Dixie J Statham
Nicholas G Martin
Michael T Lynskey
Arpana Agrawal

Funding

T32 Training Grant in Epidemiology, Services and Prevention ResearchT32DA007313 · NIDA · WASHINGTON UNIVERSITY · PI PRICE, RUMI KATO · 1999 to 2013
$2.9M
CANNABIS AND TOBACCO INVOLVEMENT: A TWIN STUDYR01DA023668 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2007 to 2016
$2.5M
Cannabis and Other Illicit Drug Use: A Twin StudyR01DA018267 · NIDA · WASHINGTON UNIVERSITY · PI LYNSKEY, MICHAEL THOMAS · 2005 to 2009
$2.4M
DELINEATING THE ROLE OF GENETIC INFLUENCES ON CANNABIS INVOLVEMENTK02DA032573 · NIDA · WASHINGTON UNIVERSITY · PI AGRAWAL, ARPANA · 2012 to 2021
$1.1M
NIDA NIH HHS DA18267NIDA NIH HHS DA23668NIDA NIH HHS K02 DA032573NIDA NIH HHS K02DA32573NIDA NIH HHS R01 DA018267NIDA NIH HHS R01 DA023668NIDA NIH HHS T32 DA007313NIDA NIH HHS T32DA007313
6 · The paper itself

Abstract

aimsTo examine the genetic overlap between borderline personality features (BPF) and substance use disorders (SUDs) and the extent to which variation in personality traits contributes to this covariance.

designGenetic structural equation modelling was used to partition the variance in and covariance between personality traits, BPF and SUDs into additive genetic, shared and individual-specific environmental factors.

settingAll participants were registered with the Australian Twin Registry.

participantsA total of 3127 Australian adult twins participated in the study. MEASUREMENTS: Diagnoses of DSM-IV alcohol and cannabis abuse/dependence (AAD; CAD) and nicotine dependence (ND) were derived via computer-assisted telephone interview. BPF and five-factor model personality traits were derived via self-report questionnaires.

findingsPersonality traits, BPF and substance use disorders were partially influenced by genetic factors with heritability estimates ranging from 0.38 (neuroticism; 95% confidence interval: 0.30-0.45) to 0.78 (CAD; 95% confidence interval: 0.67-0.86). Genetic and individual-specific environmental correlations between BPF and SUDs ranged from 0.33 to 0.56 (95% CI = 0.19-0.74) and 0.19-0.32 (95% CI = 0.06-0.43), respectively. Overall, there was substantial support for genetic influences that were specific to AAD, ND and CAD (30.76-68.60%). Finally, genetic variation in personality traits was responsible for 11.46% (extraversion for CAD) to 59.30% (neuroticism for AAD) of the correlation between BPF and SUDs.

conclusionsBoth genetic and individual-specific environmental factors contribute to comorbidity between borderline personality features and substance use disorders. A substantial proportion of this comorbidity can be attributed to variation in normal personality traits, particularly neuroticism.

Indexed as

CharacterAdultAlcoholismAnalysis of VarianceAustraliaBorderline Personality DisorderDiseases in TwinsFemaleGene-Environment InteractionGenetic VariationHumansMaleMarijuana AbuseModels, GeneticPhenotypeStatistics as TopicAlcohol use disordersborderline personality disordercannabis use disorderscomorbidityfive-factor modelgeneticsnicotine dependencepersonality traitssubstance use disorders

Identifiers

PMID25041562
PMCPMC4229407

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.